ReviewJournal of applied genetics2026
Advancements in somatic mutation detection through loop-mediated isothermal amplification (LAMP) in human tumors.
Review in Journal of applied genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Loop-mediated isothermal amplification (LAMP) is a robust and specific isothermal nucleic acid assessment technique. Due to its practicality and diverse detection strategies, LAMP has gained new insights in the analysis of somatic mutations in various tumor types, where the proportion of mutated DNA is often markedly low compared to wild-type DNA. We conducted an evaluation of articles from PubMed and Google Scholar published up to May 2025, focusing on somatic mutation detection in human cancers using LAMP. In addition to reviewing the articles found using specific keywords, we also examined and evaluated the references cited in those articles. By employing various primer design strategies specific to single base substitutions such as mismatch and loop primers, the researchers addressed the challenge of distinguishing between wild-type and mutant alleles. Furthermore, the specificity and sensitivity of the LAMP assay were enhanced by incorporating Locked Nucleic Acid (LNA) and Peptide Nucleic Acid (PNA) probes. The use of additives and adjustments in reaction conditions has also been discussed as strategies to improve reactions efficiency. LAMP demonstrates the capability to detect mutations present at levels as low as 0.1% in tumor tissues, indicating its potential for high-sensitivity mutation detection. The studies contribute to refining LAMP as a reliable, rapid, and cost-effective method for somatic mutation detection. The versatile detection approaches further enhance the utility and accessibility of the LAMP technique in various research and clinical settings. This paves the way for its broader application in clinical diagnostics and personalized medicine.
Indexed as
Identifiers
41644930What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.